Johnson & Johnson, as American as apple pie and Coca Cola. The American corporation that was founded in 1886 has provided generations of American homes with consumer staples such as baby care products, toiletries, and wound care products….and opioids. Most people associate Purdue Pharma with the opioid crisis that has ravaged parts of this country for years, but Johnson & Johnson also played a huge role in the crisis.
In the mid-1990’s, while the opioid crisis was already taking wing, Johnson & Johnson embarked upon a new business: the cultivation of poppies in Tasmania. Johnson & Johnson scientists genetically modified poppy plants, engineering “super poppies” that produced abundant opiates. Rewarding farmers in Tasmania, where the super poppies were grown, with handsome prices and incentives, such as luxury cars, Johnson & Johnson cultivated a new business through its subsidiaries. The poppies became a boom crop for the tiny island state of Tasmania. And the scientist who discovered the way to genetically modify the poppies was celebrated by Johnson & Johnson. The company gave that scientist the highest science award offered by Johnson & Johnson in the year 2000, “for the Invention of the Thebaine Alkaloid ‘Norman’ Poppy.”
The poppies—grown on thousands of Tasmanian acers– were exported to the U.S. under Drug Enforcement Administration approval. The poppies were then refined by the subsidiaries into oxycodone and hydrocodone powders that were shipped to U.S. pill makers…. such as Purdue Pharma, which become one of the first major customers for the Johnson & Johnson product.